secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2023-01-04T23:59:59+00:00
Accession:  0001493152-23-000198
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma raises $6.5M in registered direct offering of shares and warrants at $1.00 per unit
--------------------------------------------------------------------------------

- Offering of 6.5M shares or pre-funded warrants plus 6.5M warrants to purchase common stock.
- Gross proceeds of $6.5 million, before placement agent fees and expenses.
- Warrants exercisable at $1.00 per share, beginning six months after issuance, for five years.
- H.C. Wainwright & Co. acted as exclusive placement agent; cash fee of $390,000 paid.
- Net proceeds to be used for general corporate purposes; closing expected January 4, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315223000198/0001493152-23-000198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315223000198/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-000198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer